跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要围绕连续处理的因果剂量反应、正值性违反与个体化可行干预展开,因此归入因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Han Bao
Michael Schomaker

正值性违反下连续处理的可行剂量反应曲线

研究问题
当目标剂量在部分协变量分层中缺乏支持时,如何构造接近原始科学问题、又符合个体可实现范围的因果剂量反应曲线?
方法与思路
作者定义非重叠比例,把不受支持的目标剂量映射到最近可行剂量,再结合结局回归与条件密度估计进行插件式 g 计算。
材料陈述的贡献
摘要提出可行剂量反应目标及诊断工具,称模拟中正值性违反时偏差降低、支持充分时恢复标准曲线,并给出儿童 HIV 数据应用。
阅读关注点
应核对支持区域及最近剂量的定义、密度估计阈值、因果识别条件,并区分可行干预曲线与原始固定剂量干预曲线。
阅读边界
这是 arXiv 预印本,同行评审或期刊接收未核实;摘要未列出识别与支持学习条件,可行目标的解释不能直接等同于原始目标。

原文摘要

Positivity violations can complicate estimation and interpretation of causal dose-response curves (CDRCs) for continuous interventions. Weighting-based methods are designed to handle limited overlap, but the resulting weighted targets can be hard to interpret scientifically. Modified treatment policies can be less sensitive to support limitations, yet they typically target policy-defined effects that may not align with the original dose-response question. We develop an approach that addresses limited overlap while remaining close to the scientific target of the CDRC. Our work is motivated by the CHAPAS-3 trial of HIV-positive children in Zambia and Uganda, where clinically relevant efavirenz concentration levels are not uniformly supported across covariate strata. We introduce a diagnostic, the non-overlap ratio, which quantifies, as a function of the target intervention level, the proportion of the population for whom that level is not supported given observed covariates. We also define an individualized most feasible intervention: for each child and target concentration, we retain the target when it is supported, and otherwise map it to the nearest supported concentration. The resulting feasible dose-response curve answers: if we try to set everyone to a given concentration, but it is not realistically attainable for some individuals, what outcome would be expected after shifting those individuals to their nearest attainable concentration? We propose a plug-in g-computation estimator that combines outcome regression with flexible conditional density estimation to learn supported regions and evaluate the feasible estimand. Simulations show reduced bias under positivity violations and recovery of the standard CDRC when support is adequate. An application to CHAPAS-3 yields a stable and interpretable concentration-response summary under realistic support constraints.

笔记与分组
相关领域论文